Antioxidant therapy with a whole, leech saliva extract
Methods are provided for isolating and using a whole-saliva leech extract. The methods can include feeding a phagostimulatory agent to a leech; inducing a regurgitation in the leech, the inducing including placing the leech in an environment having a temperature of less than about 0° C.; and, collecting an unrefined, whole saliva in the regurgitation of the cooled leech. The methods can include revitalizing the leech by warming it at a temperature ranging from about 5° C. to about 40° C. Stable, lyophilized, whole-saliva extracts of a leech are also provided, the extract having a stable activity when stored for use at a temperature below about −20° C., the extract maintaining at least 70% of the activity for at least 6 months. The extracts can be used to treat solid tumors, treat liquid tumors, treat diabetes, treat a viral disease, treat a parasitic disease, treat an antibacterial disease, or serve as an anti-oxidant.
1. A method of scavenging free radicals, comprising
contacting a free radical in a fluid with a whole, leech saliva extract; wherein,
the contacting includes scavenging the free radicals in the fluid; and,
the extract has a peptide molecular weight distribution with molecular weights of 3496 Daltons or greater wherein the extract is produced from a process comprising: feeding a phagostimulatory agent to a leech; inducing a regurgitation in the leech, the inducing including placing the leech in an environment having a temperature of less than 0° C. or about 0° C.; and, collecting an unrefined, whole saliva in the regurgitation of the cooled leech.
2. The method of claim 1 , wherein the collecting includes squeezing the leech to increase the amount of unrefined, whole saliva collected.
3. The method of claim 1 , further comprising revitalizing the leech by warming the leech in a water bath having a temperature ranging from about 5° C. to about 40° C.
4. The method of claim 1 , wherein the method further comprises creating a refined, whole-saliva extract; the creating including removing solid components from the unrefined, whole saliva.
5. The method of claim 1 , wherein the method further comprises lyophilizing separate volumes of the refined, whole saliva extract, the volumes not exceeding about 2 ml each.
6. The method of claim 1 , the leech being Hirudinaria manillensis.
7. A method of scavenging free radicals, comprising contacting a free radical in a fluid with a whole, leech saliva extract, wherein the contacting includes scavenging the free radicals in the fluid; wherein the extract has a peptide molecular weight distribution with molecular weights of 3496 Daltons or greater, and wherein the extract is a lyophilized, whole saliva extract of a leech produced from a method comprising:
feeding a phagostimulatory agent to a leech;
inducing regurgitation in the leech, the inducing including placing the leech in an environment having a temperature ranging from about −5° C. to about 15° C.
collecting an unrefined, whole saliva in the regurgitation of the cooled leech;
removing solid components from the unrefined, whole saliva to create a refined, whole saliva; and,
lyophilizing separate volumes of the refined, whole saliva extract, the volumes not exceeding about 2 ml each.
8. The method of claim 7 , wherein the collecting includes squeezing the leech to increase the amount of unrefined, whole saliva collected.
9. The method of claim 7 , further comprising revitalizing the leech by warming the leech in a water bath having a temperature ranging from about 5° C. to about 40° C.
10. The method of claim 7 , the leech being Hirudinaria manillensis.
11. The method of claim 7 , wherein the collecting of the whole saliva yields a peptide molecular weight distribution that ranges from 4276 Daltons to 44386 Daltons.
12. The method of claim 7 , wherein the collecting of the whole saliva yields a peptide molecular weight distribution that ranges from 6289 Daltons to 14244 Daltons.
13. The method of claim 7 , wherein the collecting of the whole saliva yields a peptide molecular weight distribution that ranges from 10812 Daltons to 88210 Daltons.
14. The method of claim 7 , wherein the collecting of the whole saliva yields a peptide molecular weight distribution that ranges from 3496 Daltons to 88210 Daltons.
15. The method of claim 1 , wherein the fluid is in a subject in need of an antioxidant therapy, and the antioxidant therapy is used to treat an arthritis.
16. The method of claim 1 , wherein the fluid is in a subject in need of an antioxidant therapy, and the antioxidant therapy is used to treat an inflammatory disorder.
17. The method of claim 1 , wherein the fluid is in a subject in need of an antioxidant therapy, and the antioxidant therapy is used to treat a cardiovascular disease.
18. The method of claim 1 , wherein the fluid is in a subject in need of an antioxidant therapy, and the antioxidant therapy is used to treat atherosclerosis.
19. The method of claim 1 , wherein the extract is administered in combination with an absorption blocker in the treatment of cardiovascular disease.
20. The method of claim 1 , wherein the extract is administered in combination with a synthesis inhibitor in the treatment of cardiovascular disease.
21. The method of claim 1 , wherein the extract is administered in combination with a niacin-based drug in the treatment of cardiovascular disease.
22. The method of claim 1 , wherein the fluid is in a subject in need of an antioxidant therapy, and the antioxidant therapy is used to treat aging.
23. The method of claim 1 , wherein the fluid is in a subject in need of an antioxidant therapy, and the antioxidant therapy is used as a neuroprotective treatment.